1.
BMJ Case Rep
; 15(11)2022 Nov 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36414352
RESUMO
We describe inflammatory vaginitis as a potential side effect of long-term rituximab treatment for multiple sclerosis in the absence of any other systemic disease or underlying malignancy.More studies are needed to characterise the incidence of inflammatory vaginitis among women on long-term rituximab therapy.